Switch theme
Sign up to access all valuation multiples
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia Pacific, Europe and the rest of the world.
2000
416
LTM Revenue $129M
LTM EBITDA $60.0M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
RaySearch Labs has a last 12-month revenue (LTM) of $129M and a last 12-month EBITDA of $60.0M.
In the most recent fiscal year, RaySearch Labs achieved revenue of $123M and an EBITDA of $58.9M.
RaySearch Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX
See RaySearch Labs valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $129M | XXX | $123M | XXX | XXX | XXX |
| Gross Profit | $119M | XXX | $113M | XXX | XXX | XXX |
| Gross Margin | 92% | XXX | 92% | XXX | XXX | XXX |
| EBITDA | $60.0M | XXX | $58.9M | XXX | XXX | XXX |
| EBITDA Margin | 46% | XXX | 48% | XXX | XXX | XXX |
| EBIT | $29.3M | XXX | $25.9M | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 21% | XXX | XXX | XXX |
| Net Profit | $22.8M | XXX | $21.0M | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 17% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, RaySearch Labs's stock price is SEK 305 (or $32).
RaySearch Labs has current market cap of SEK 10.5B (or $1.1B), and EV of SEK 10.4B (or $1.1B).
See RaySearch Labs trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $1.1B | XXX | XXX | XXX | XXX | $0.65 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, RaySearch Labs has market cap of $1.1B and EV of $1.1B.
RaySearch Labs's trades at 8.7x EV/Revenue multiple, and 18.2x EV/EBITDA.
Equity research analysts estimate RaySearch Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
RaySearch Labs has a P/E ratio of 47.4x.
See valuation multiples for RaySearch Labs and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV/Revenue | 8.3x | XXX | 8.7x | XXX | XXX | XXX |
| EV/EBITDA | 17.9x | XXX | 18.2x | XXX | XXX | XXX |
| EV/EBIT | 36.7x | XXX | 41.4x | XXX | XXX | XXX |
| EV/Gross Profit | 9.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 47.4x | XXX | 51.5x | XXX | XXX | XXX |
| EV/FCF | 45.3x | XXX | 38.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialRaySearch Labs's last 12 month revenue growth is 13%
RaySearch Labs's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
RaySearch Labs's rule of 40 is 53% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
RaySearch Labs's rule of X is 79% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for RaySearch Labs and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 46% | XXX | 48% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 23% | XXX | XXX | XXX |
| Rule of 40 | 53% | XXX | 61% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 79% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 27% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 23% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 71% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
RaySearch Labs acquired XXX companies to date.
Last acquisition by RaySearch Labs was XXXXXXXX, XXXXX XXXXX XXXXXX . RaySearch Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was RaySearch Labs founded? | RaySearch Labs was founded in 2000. |
| Where is RaySearch Labs headquartered? | RaySearch Labs is headquartered in Sweden. |
| How many employees does RaySearch Labs have? | As of today, RaySearch Labs has 416 employees. |
| Who is the CEO of RaySearch Labs? | RaySearch Labs's CEO is Mr. Johan Lof. |
| Is RaySearch Labs publicy listed? | Yes, RaySearch Labs is a public company listed on STO. |
| What is the stock symbol of RaySearch Labs? | RaySearch Labs trades under RAY B ticker. |
| When did RaySearch Labs go public? | RaySearch Labs went public in 1991. |
| Who are competitors of RaySearch Labs? | Similar companies to RaySearch Labs include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of RaySearch Labs? | RaySearch Labs's current market cap is $1.1B |
| What is the current revenue of RaySearch Labs? | RaySearch Labs's last 12 months revenue is $129M. |
| What is the current revenue growth of RaySearch Labs? | RaySearch Labs revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of RaySearch Labs? | Current revenue multiple of RaySearch Labs is 8.3x. |
| Is RaySearch Labs profitable? | Yes, RaySearch Labs is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of RaySearch Labs? | RaySearch Labs's last 12 months EBITDA is $60.0M. |
| What is RaySearch Labs's EBITDA margin? | RaySearch Labs's last 12 months EBITDA margin is 46%. |
| What is the current EV/EBITDA multiple of RaySearch Labs? | Current EBITDA multiple of RaySearch Labs is 17.9x. |
| What is the current FCF of RaySearch Labs? | RaySearch Labs's last 12 months FCF is $23.7M. |
| What is RaySearch Labs's FCF margin? | RaySearch Labs's last 12 months FCF margin is 18%. |
| What is the current EV/FCF multiple of RaySearch Labs? | Current FCF multiple of RaySearch Labs is 45.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
